Iterative Psychopharmacology: How to Decide What to Do When First or Second Interventions Fail
The goal of this program is to improve the knowledge and competence of learners in effort to optimize treatment for patients with Psychiatry
Clinical Care Options, LLC
Navigating Cannabis Use in Psychiatric Populations: Drug-Drug Interactions and Other Pharmacologic Considerations
The goal of this program is to improve the knowledge and competence of learners in effort to optimize treatment for patients with Psychiatry
Estrogen and Mood: Psychiatric Considerations Over the Reproductive Lifecycle
The goal of this program is to improve the knowledge and competence of learners in effort to optimize treatment for patients with Psychiatry
Sutures, Psych, and Sobriety: Tying together psychiatric post-op support for at-risk patients
The goal of this program is to improve the knowledge and competence of learners in effort to optimize treatment for patients with Opioid Dependence
Innovative Approaches for PTSD: Unraveling Pathophysiology and New Treatment Frontiers
The goal of this program is to improve the knowledge, competence, and performance of learners in effort to optimize treatment for patients with Psychiatry
Agitation, Psychosis, and Other Behavioral Issues in Alzheimer’s Dementia
The goal of this program is to improve the knowledge, competence, and performance of learners in effort to optimize treatment for patients with Alzheimer’s
Insights into Tardive Dyskinesia in Aging Populations
The goal of this program is to improve the knowledge, competence, and performance of learners in effort to optimize treatment for patients with Tardive Dyskinesia (TD)
Clusters of Concerns: Neurobiology and Treatment of Psychiatric Disorder Comorbidities
The goal of this program is to improve the knowledge and competence of learners in effort to optimize treatment for patients with Psychiatry
Innovation Insight: How are Novel Agents Reshaping Schizophrenia’s Landscape?
In this session, participants will review the mechanism of disease of schizophrenia and hear about the potential impact of novel agents in changing the landscape of schizophrenia treatment in addressing symptom domains and adverse event profiles.
Medical Minute 6—Enabling Successful Transitions of Care With LAI Antipsychotics
In part 6 of this 6-part CME/CE/CPE-certified Medical Minute series, review the basic LAI kinetic properties that make oral overlap necessary and discuss the oral overlap required for different preparations of LAI antipsychotic preparations when transitioning an oral antipsychotic to…
